1 / 6

Supplemental Figure 1.

Supplemental Figure 1. A. GCN1L1. B. DSP. C. RCN3. D. AKR1B10. E. PDIA4. F. CTSB. Supplemental Figure 1. Cont. G. EIF5A. H. SERPINB5. I. TPD52. Supplemental Figure 2. A. Biological process. B. Cellular component. Supplemental Figure 3. A. C. B. A549. Cont. Sh1. Cont. Sh1.

zora
Download Presentation

Supplemental Figure 1.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1. A. GCN1L1 B. DSP C. RCN3 D. AKR1B10 E. PDIA4 F. CTSB

  2. Supplemental Figure 1. Cont. G. EIF5A H. SERPINB5 I. TPD52

  3. Supplemental Figure 2. A. Biological process B. Cellular component

  4. Supplemental Figure 3. A. C. B. A549 Cont Sh1 Cont Sh1 Abs. 460- 690 a-PAK2 10%FBS +1uM IPA3 10%FBS +10uM IPA3 a-bactin No FBS 10%FBS Days D. E. Number of cells Number of cells 10%FBS +1uM IPA3 10%FBS +10uM IPA3 No FBS 10%FBS

  5. Supplemental Figure4. 164 candidates 12 candidates tested with commercial Elisa 30 candidates tested with commercial and in house-ELISAs 15 controls 15 SCC 15 ADC 15 controls 15 SCC 15 ADC Supplemental Figure 5 Supplemental Table 11 9 candidates 41 SCC 34 controls 6 candidates 45 ADC 49 controls Supplemental Table 12-15

  6. Supplemental Figure 5.

More Related